Dianthus Therapeutics | MGTA - Pre Tax Profit


Dianthus Therapeutics reported $-64.43M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Moderna USD -187M 631M Sep/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Sartorius EUR 85M 14.1M Sep/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zealand Pharma A/S -406.5M 39.77M Dec/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025